ArticleJournal of oncology2022

A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma.

Junqing Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.